| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-08 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-08 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.23 | 5e-08 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-08 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-08 |